查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1625477

鉑類抗癌藥物市場規模、佔有率、趨勢、行業分析報告（按類型、應用、分銷管道和地區）- 市場預測，2025-2034 年

Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，全球鉑類抗癌藥物市場預計到2034年將達到27.3324億美元。該報告提供了有關當前市場動態的詳細見解，並對未來市場的成長進行了分析。

卵巢癌、肺癌和大腸直腸癌等各種癌症的發生率不斷上升，這些癌症需要有效的化療，這推動了鉑類抗癌藥物市場的成長。主要的市場推動因素包括順鉑、卡鉑和奧沙利鉑等鉑類藥物在治療實體瘤方面的持續有效性、聯合療法的進步以及改善治療結果的個人化醫療。新興市場也存在機遇，因為這些市場的癌症治療管道正在不斷擴大，而新藥配方的開發也旨在減少副作用和改善藥物傳輸。

鉑基抗癌藥物的市場趨勢，例如聯合療法的增加、對降低毒性的注重以及鉑類藥物仿製藥的增加，可能會在預測期內促進整體市場的擴張。隨著鉑類藥物研究的進步和新用途的探索，預計市場將繼續成長，以滿足對更好的癌症治療的需求和全球對更便宜治療的需求。

鉑類抗癌藥物市場報告重點

按類型劃分，順鉑因其在治療包括卵巢癌和睪丸癌在內的各種癌症方面的長期有效應用而佔據鉑類癌症治療市場佔有率的主導地位。不過，應用於結腸癌治療及合併治療的奧沙利鉑類藥物成長速度最快。

由於順鉑和卡鉑等鉑類藥物具有較高的治療效果，卵巢癌在應用領域佔據了最大的市場佔有率。肺癌是成長最快的領域，主要是由於非小細胞肺癌發生率的增加以及鉑類藥物與其他藥物的聯合使用。

根據分銷管道，市場由醫院藥房主導，醫院藥房是住院和癌症治療化療藥物（包括鉑類藥物）的主要供應商。受遠距醫療趨勢以及患者續藥和門診護理便利性的提高的推動，網路藥局正經歷最快的成長。

北美佔據全球市場的最大佔有率，這主要歸功於該地區先進的醫療保健基礎設施和較高的癌症發病率。亞太地區是成長最快的地區，主要原因是癌症發生率上升、醫療保健機會改善以及中國和印度等國家對鉑類藥物的採用增加。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章 研究方法

第 4 章。
  • 市場概況
  • 鉑類抗癌藥物市場動態
    • 推動因素和機遇
      • 越來越多採用鉑類癌症化療
      • 正在進行的聯合療法研究
    • 阻礙因素和課題
      • 成本高
  • PESTEL 分析
  • 鉑類抗癌藥物市場通路趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第 5 章。
  • 主要發現
  • 簡介
  • 順鉑
  • 奧沙利鉑
  • 卡鉑
  • 其他

6. 全球鉑類腫瘤藥物市場（依應用）

  • 主要發現
  • 簡介
  • 大腸癌
  • 卵巢癌
  • 肺癌
  • 其他

7. 全球鉑類腫瘤藥物市場依通路劃分

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局

8. 全球鉑類腫瘤藥物市場（按地區）

  • 主要發現
  • 簡介
      鉑類腫瘤藥物市場評估（地區），2020 年至 2034 年
  • 北美洲
      2020 年至 2034 年北美各類型
    • 2020 年至 2034 年北美各應用領域 2020 年至 2034 年北美按通路劃分
    • 美國
    • 加拿大
  • 歐洲
      2020 年至 2034 年歐洲各類型 2020 年至 2034 年歐洲應用狀況 2020 年至 2034 年歐洲按通路劃分
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
    亞太地區
      2020 年至 2034 年亞太地區各類產品 2020 年至 2034 年亞太地區應用情況 2020 年至 2034 年亞太地區通路分佈
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
      2020 年至 2034 年中東和非洲各類型 2020 年至 2034 年中東和非洲的應用狀況 2020 年至 2034 年中東和非洲按分銷管道劃分
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
      2020 年至 2034 年拉丁美洲各類型
    • 2020 年至 2034 年拉丁美洲各應用領域狀況 2020 年至 2034 年拉丁美洲按通路劃分
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第 9 章 競爭格局

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協定/揭露

第十章 公司簡介

  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Sanofi
  • Pfizer
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical Industries
  • Hikma Pharmaceuticals
  • Mylan
  • AstraZeneca
  • GlaxoSmithKline
  • Bayer
  • Merck & Co.
  • Amgen
  • Sun Pharmaceutical Industries
Product Code: PM1635

The global platinum-based cancer drugs market size is expected to reach USD 2,733.24 million by 2034, according to a new study by Polaris Market Research. The report "Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Cisplatin, Oxaliplatin, Carboplatin, and Others), Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle, East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of various cancers, such as ovarian, lung, and colorectal cancer, that require effective chemotherapy treatments drives the platinum-based cancer drugs market growth. Key market growth drivers include the continued effectiveness of platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin in treating solid tumors and advancements in combination therapies and personalized medicine that enhance treatment outcomes. Opportunities exist in emerging markets where access to cancer treatments is expanding, as well as in the development of new drug formulations aimed at reducing side effects and improving drug delivery.

A few platinum-based cancer drugs market trends such as the rise of combination therapies, the focus on reducing toxicity, and the growing availability of generic platinum drugs would contribute to the market's overall expansion during the forecast period. As research progresses and new applications for platinum-based drugs are explored, the market is poised for continued growth, addressing both the demand for better cancer treatments and the need for affordable therapies worldwide.

Platinum-Based Cancer Drugs Market Report Highlights

Based on type, the Cisplatin segment dominates the platinum-based cancer drugs market share due to its long-standing use and effectiveness in treating various cancers, including ovarian and testicular cancer. However, the oxaliplatin segment is the fastest-growing, driven by its increasing application in colorectal cancer treatments and combination therapies.

The ovarian cancer segment, by application, holds the largest market share, owing to the high efficacy of platinum-based drugs such as cisplatin and carboplatin in treating this cancer. Lung cancer is the fastest-growing segment, primarily due to the rising incidence of non-small cell lung cancer and the use of platinum-based therapies in combination with other drugs.

By distribution channel, the hospital-based pharmacies segment dominates the market as they are the primary providers of chemotherapy drugs, including platinum-based treatments, for inpatient care and cancer treatments. Online pharmacies are experiencing the highest growth, driven by the increasing trend of remote healthcare and patient convenience for prescription refills and outpatient treatments.

North America holds the largest share of the global market, largely due to advanced healthcare infrastructure and high cancer incidence rates in the region. Asia Pacific is the highest-growing region, fueled by the increasing cancer burden, improving healthcare access, and rising adoption of platinum-based therapies in countries such as China and India.

Polaris Market Research has segmented the platinum-based cancer drugs market report on the basis of type, application, distribution channel, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Others

By Application Outlook (Revenue - USD Million, 2020-2034)

  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Platinum-Based Cancer Drugs Market Insights

  • 4.1. Platinum-Based Cancer Drugs Market - Market Snapshot
  • 4.2. Platinum-Based Cancer Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Adoption of Platinum-Based Chemotherapy in Cancer Treatment
      • 4.2.1.2. Ongoing Research in Combination Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Platinum-Based Cancer Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Platinum-Based Cancer Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • 5.3. Cisplatin
    • 5.3.1. Global Platinum-Based Cancer Drugs Market, by Cisplatin, by Region, 2020-2034 (USD Million)
  • 5.4. Oxaliplatin
    • 5.4.1. Global Platinum-Based Cancer Drugs Market, by Oxaliplatin, by Region, 2020-2034 (USD Million)
  • 5.5. Carboplatin
    • 5.5.1. Global Platinum-Based Cancer Drugs Market, by Carboplatin, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Platinum-Based Cancer Drugs Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • 6.3. Colorectal Cancer
    • 6.3.1. Global Platinum-Based Cancer Drugs Market, by Colorectal Cancer, by Region, 2020-2034 (USD Million)
  • 6.4. Ovarian Cancer
    • 6.4.1. Global Platinum-Based Cancer Drugs Market, by Ovarian Cancer, by Region, 2020-2034 (USD Million)
  • 6.5. Lung Cancer
    • 6.5.1. Global Platinum-Based Cancer Drugs Market, by Lung Cancer, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Platinum-Based Cancer Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.3. Hospital-Based Pharmacies
    • 7.3.1. Global Platinum-Based Cancer Drugs Market, by Hospital-Based Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Platinum-Based Cancer Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Platinum-Based Cancer Drugs Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Platinum-Based Cancer Drugs Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Platinum-Based Cancer Drugs Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Platinum-Based Cancer Drugs Market - North America
    • 8.3.1. North America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.4. Platinum-Based Cancer Drugs Market - U.S.
      • 8.3.4.1. U.S.: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.5. Platinum-Based Cancer Drugs Market - Canada
      • 8.3.5.1. Canada: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.4. Platinum-Based Cancer Drugs Market - Europe
    • 8.4.1. Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.4. Platinum-Based Cancer Drugs Market - UK
      • 8.4.4.1. UK: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.5. Platinum-Based Cancer Drugs Market - France
      • 8.4.5.1. France: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.6. Platinum-Based Cancer Drugs Market - Germany
      • 8.4.6.1. Germany: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.7. Platinum-Based Cancer Drugs Market - Italy
      • 8.4.7.1. Italy: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.8. Platinum-Based Cancer Drugs Market - Spain
      • 8.4.8.1. Spain: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.9. Platinum-Based Cancer Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.10. Platinum-Based Cancer Drugs Market - Russia
      • 8.4.10.1. Russia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.11. Platinum-Based Cancer Drugs Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.5. Platinum-Based Cancer Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.4. Platinum-Based Cancer Drugs Market - China
      • 8.5.4.1. China: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.5. Platinum-Based Cancer Drugs Market - India
      • 8.5.5.1. India: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.6. Platinum-Based Cancer Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.7. Platinum-Based Cancer Drugs Market - Japan
      • 8.5.7.1. Japan: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.8. Platinum-Based Cancer Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.9. Platinum-Based Cancer Drugs Market - South Korea
      • 8.5.9.1. South Korea: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.10. Platinum-Based Cancer Drugs Market - Australia
      • 8.5.10.1. Australia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.11. Platinum-Based Cancer Drugs Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.6. Platinum-Based Cancer Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.4. Platinum-Based Cancer Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.5. Platinum-Based Cancer Drugs Market - UAE
      • 8.6.5.1. UAE: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.6. Platinum-Based Cancer Drugs Market - Israel
      • 8.6.6.1. Israel: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.7. Platinum-Based Cancer Drugs Market - South Africa
      • 8.6.7.1. South Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.8. Platinum-Based Cancer Drugs Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.7. Platinum-Based Cancer Drugs Market - Latin America
    • 8.7.1. Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.4. Platinum-Based Cancer Drugs Market - Mexico
      • 8.7.4.1. Mexico: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.5. Platinum-Based Cancer Drugs Market - Brazil
      • 8.7.5.1. Brazil: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.6. Platinum-Based Cancer Drugs Market - Argentina
      • 8.7.6.1. Argentina: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.7. Platinum-Based Cancer Drugs Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bristol-Myers Squibb
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Eli Lilly and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Sanofi
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Pfizer
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Novartis
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Teva Pharmaceutical Industries
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Hikma Pharmaceuticals
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mylan
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. AstraZeneca
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. GlaxoSmithKline
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Bayer
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Merck & Co.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Amgen
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sun Pharmaceutical Industries
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables:

  • Table 1 Global Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 4 North America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 6 North America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 U.S.: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 8 U.S.: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 9 U.S.: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 10 Canada: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 12 Canada: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 15 Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 16 UK: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 18 UK: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 19 France: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 21 France: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 22 Germany: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 24 Germany: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 25 Italy: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 27 Italy: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 28 Spain: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 30 Spain: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 31 Netherlands: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 33 Netherlands: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 34 Russia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 36 Russia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 43 China: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 45 China: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 46 India: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 48 India: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 49 Malaysia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 51 Malaysia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 52 Japan: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 54 Japan: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 55 Indonesia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 57 Indonesia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 58 South Korea: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 60 South Korea: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 61 Australia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 63 Australia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 73 UAE: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 75 UAE: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 76 Israel: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 78 Israel: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 79 South Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 81 South Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 85 Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 87 Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 88 Mexico: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 90 Mexico: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 91 Brazil: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 93 Brazil: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 94 Argentina: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 96 Argentina: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global Platinum-Based Cancer Drugs Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Platinum-Based Cancer Drugs Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Platinum-Based Cancer Drugs Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2024 & 2034 (USD Million)